Status: Not yet recruiting
Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework
To evaluate the efficacy and safety of Honghua Xiaoyao tablets in the treatment of premenstrual syndrome, and the results were further analyzed and evaluated by target trial simulation (TTE) framework.
Participants needed: 266
Trial details
Age: 18-40Biological sex: FemaleType: ObservationalSponsor: Lianxin WangUpdated: Sep 15, 2025Duration: 4 Months
Eligibility criteria
Age:18-40 years old (both ends included); [+2]
those who were allergic to the ingredients and excipients of Honghua Xiaoyao tab... [+5]